24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
How Moving the Homeless to Hotels During the Pandemic Helps EveryoneA Vaccine Against UTIs? New Mouse Study Brings Shot CloserOpioid Use (and Overuse) for Knee Arthritis Takes Big Financial TollFormaldehyde in Hair Straighteners Prompts FDA WarningIt's Too Soon to Lift COVID Restrictions: FauciWith 3 COVID Vaccines Approved, Is There a 'Best' Shot?U.S. Hispanics at High Stroke Risk and Many Go Untreated: ReportCOVID Leaves Most Pro Athletes With No Lasting Heart Damage: StudyAmerican Indians Face the Highest Odds for StrokePerils of the Pandemic: Scooters, Cleansers and Button BatteriesModerna COVID Vaccine Can Sometimes Trigger Delayed Skin ReactionsMore Data Suggests New Coronavirus Variants Weaken Vaccines, TreatmentsAdd Sleep Woes to Long-Term Effects of ConcussionsCOVID Death Rates 10 Times Higher in Countries Where Most Are Overweight: ReportCould Taking a Swing at Golf Help Parkinson's Patients?Scientists Discover Why Blood Type May Matter for COVID InfectionNew Coronavirus Variant Out of Brazil Now in 5 U.S. StatesScientists Gain Insight Into Genetics of GlaucomaPatients With Sickle Cell Disease Often Overlooked for Life-Saving Kidney TransplantsDoes an Arthritis Drug Help Patients Battling Severe COVID? It Depends on the StudyNIH Halts Trial of Convalescent Plasma for Mild COVID-19COVID Vaccines for All American Adults by the End of May: BidenWhat You Need to Know About the New J&J COVID VaccineHow Climate Change Could Put More MS Patients in DangerFace Masks Won't Impede Your Breathing, Study ConfirmsSports Position Doesn't Affect Risk of Concussion-Linked CTE IllnessStrep Throat Doesn't Worsen Tourette But May Affect ADHD: StudyFauci Says U.S. Will Stay With Two Doses of Pfizer, Moderna VaccinesAHA News: Finally Getting Around to That Annual Physical? Here's What You Might FindStem Cell Injections Show Early Promise Against Spinal Cord InjuriesStudy Debunks Notion That Statin Meds Trigger Muscle AchesMore Than 87,000 Scientific Papers Already Published on COVID-19Underarm Lump After COVID Shot Is Likely Lymph Swelling, Not Breast Cancer, Experts SayVaccinating Oldest First for COVID Saves the Most Lives: StudyIf Protections Expire, COVID Patients Could Soon Face Big Medical BillsSharp Drop Seen in COVID Testing As New Cases PlateauFDA Approves Third COVID VaccineSpring Allergies Are Near, Here's What Works to Fight ThemRheumatoid Arthritis Meds May Help Fight Severe COVID-19Hair Salon Talk Can Spread COVID, But Face Shields Cut the DangerPandemic Is Hitting Hospitals Hard, Including Their Bottom LineExpert Panel Set to Consider Approval of J&J COVID VaccineIn Israel, Widespread Vaccination Slashes Severe COVID Cases in Older PatientsMental Health 'Epidemic' Threatens Communities of Color Amid COVID-19Masks Vital to Stopping COVID at Gyms, Studies ShowAs Climate Change Lengthens Allergy Season, Pollen Travels FartherVery Low COVID Infection Rate Among Dental Hygienists: StudyPandemic Is Adding to Teachers' Stress, and Quit RatesCOVID Cases, Deaths Plummet in Nursing Homes After Vaccine RolloutAHA News: What's Safe Once You've Had Your COVID-19 Vaccine?
Questions and AnswersLinks
Related Topics

Diabetes

Black Patients at Higher Risk When Type 1 Diabetes and COVID Combine

HealthDay News
by By Cara Murez HealthDay Reporter
Updated: Jan 8th 2021

new article illustration


FRIDAY, Jan. 8, 2021 (HealthDay News) -- The coronavirus pandemic has highlighted health care disparities in the United States, but a new study puts that issue into sharper focus, finding that Black and Hispanic people with type 1 diabetes who get COVID-19 are much more likely to have serious complications or die.

The study found that Black people with type 1 diabetes and COVID-19 were nearly four times more likely to be hospitalized for diabetic ketoacidosis, a very serious condition that can be fatal even without complications from the novel coronavirus.

"I think, most people won't be surprised that there are inequities, but I feel most people get surprised at the magnitude of the inequities. Almost four times, that's really significant once you think of all the population in general. The depths of inequities … is something that calls for more attention," said study author Dr. Osagie Ebekozien, vice president for quality improvement and population health at the T1D Exchange in Boston.

Diabetic ketoacidosis (DKA) happens when a person's body produces high levels of blood acids. In addition to finding much higher numbers of DKA in Black and Hispanic patients, the researchers also found that these patients had worse glycemic control and were less likely to use diabetes technology, such as continuous glucose monitors and insulin pumps, than white patients.

In the study, published Jan. 7 in the Journal of Clinical Endocrinology & Metabolism, the researchers analyzed data from 180 people with type 1 diabetes and COVID-19, from 52 clinical sites in the United States between April and August 2020.

Ebekozien called the study the first major examination of racial/ethnic inequities for people with type 1 diabetes and COVID-19. He urged targeted interventions, including culturally appropriate diabetic ketoacidosis awareness campaigns and increased continuous glucose monitoring coverage for minority patients.

The problem is systemic, said study co-author Dr. Shivani Agarwal, an assistant professor in the department of medicine at Albert Einstein College of Medicine in New York City.

Among other issues, there's a history of mistrust between minority populations and the health care system. It's possible that patients may not have received proper care earlier because they didn't feel they could trust their physicians, she said.

A hospital stay can impact many other parts of a person's life, Agarwal added. They've left behind responsibilities and, if they survive, they may lose their jobs. They're left with medical bills.

"Having one DKA episode can be quite intrusive into all kinds of parts of life that you wouldn't necessarily think about. It's not just the medical implications," Agarwal noted.

Type 1 diabetes is less common than type 2 diabetes, representing about 5% to 10% of people who have diabetes, according to the U.S. Centers for Disease Control and Prevention. It happens when the pancreas doesn't make or makes too little insulin, a hormone that helps blood sugar enter cells, according to the CDC.

Continuous glucose monitoring (CGM) allows for real-time monitoring by the patient of their own blood sugar, so they can catch issues before the problem is so big they have to go to the hospital, Agarwal said. It has the potential to stave off DKA altogether, she explained.

"CGM helps the patient connect with their health care provider in real time," Agarwal said.

That minority patients are less likely to have this technology is a multipronged issue, Agarwal said. In some states, the issue is insurance coverage, but her research has shown that providers also aren't offering the technologies to patients. Racism or implicit bias is what's happening, Agarwal said.

Ebekozien said he has also been considering distribution of the COVID-19 vaccines and equity, as they become available to the public.

"I think we have opportunities to ensure that we are very intentional in equitable distribution of the vaccines," Ebekozien said.

At a fundamental level, systemic issues have led to poorer outcomes for people of color, said Dr. Robert Gabbay, chief scientific and medical officer for the American Diabetes Association (ADA).

"Everybody with diabetes should have access to healthy foods. That is not the case and that disproportionately affects people of color. Everybody with diabetes should have access to the technology that helps them best manage their diabetes," Gabbay said. "Everyone should have access to the medications to treat their disease."

About 40% of people dying from COVID-19 in the United States have diabetes, Gabbay added.

The ADA is addressing some of these issues with advocacy and education, including through its Health Equity Now initiative.

"You can see how all of these things layered on top of each other are part of this," Gabbay said. "And then, you throw out the impact of COVID, where the racial disparities in outcomes are really incredible, five times as likely to be hospitalized, mortality significantly higher. So, we really feel that it's the confluence of these multiple factors."

More information

The U.S. Centers for Disease Control and Prevention has more on the impact of certain health conditions, including diabetes, and COVID-19.

SOURCES: Osagie Ebekozien, MD, MPH, assistant professor, population health, University of Mississippi Medical Center, Jackson, and vice president, quality improvement and population health, T1D Exchange, Boston; Shivani Agarwal, MD, MPH, assistant professor, department of medicine, Albert Einstein College of Medicine, New York City; Robert Gabbay, MD, PhD, chief scientific and medical officer, American Diabetes Association; The Journal of Clinical Endocrinology & Metabolism, Jan. 7, 2021